ALKBH5 and melanoma: A lower lactate concentration is accompanied by a smaller proportion of suppressive immune cells (Tregs and MDSCs) in the TIME, which notably harbor ALKBH5 deletions or mutations and typically predict sensitive responses and favorable efficacy of anti‐PD‐1 treatment in melanoma patients.26